---
kind: "section"
citation: "21 C.F.R. § 316.4"
title: "21"
number: "316.4"
heading: "Address for submissions."
url: "https://uscodex.org/cfr/21/316.4"
---

# §316.4. Address for submissions.


All correspondence and requests for FDA action under the provisions of this rule should be addressed as follows: Office of Orphan Products Development, Food and Drug Administration, Bldg. 32, Rm. 5271, 10903 New Hampshire Ave., Silver Spring, MD 20993.


## Notes

### Amendments

[78 FR 35133, June 12, 2013]

### Authority

Authority: 21 U.S.C. 360aa, 360bb, 360cc, 360dd, 371.

### Source

Source: 57 FR 62085, Dec. 29, 1992, unless otherwise noted.

### Amendments

[78 FR 35133, June 12, 2013]